Return to Trial Database

HCRN-GI19-414

Molecularly Driven, Immune-Based, Maintenance Niraparib and Dostarlimab in Advanced Stage Cholangiocarcinoma

Status

Study Completed

Cancer Type(s)

Cholangiocarcinoma

Study Contact

Trial Locations

All sites in which the trial HCRN-GI19-414 being conducted in.

No data was found